Compliance · 5 min read
FDA 21 CFR Part 211 Calibration Requirements for Pharma & Biotech
FDA’s drug GMPs mention calibration in few words but inspect it in depth. Here’s where calibration lives in 21 CFR Part 211, what investigators cite on 483s, and how to build records that close the conversation.
The two clauses that matter
§211.68 (automatic, mechanical, and electronic equipment) requires that equipment used in manufacturing, processing, packing, and holding be routinely calibrated, inspected, or checked according to a written program designed to assure proper performance — with written records of those checks maintained.
§211.160(b)(4) covers the laboratory: instruments, apparatus, gauges, and recording devices must be calibrated at suitable intervals in accordance with an established written program containing specific directions, schedules, limits for accuracy and precision, and provisions for remedial action when limits are not met — and instruments not meeting specifications must not be used.
What shows up on 483s
Common calibration observations follow the regulation’s own words: no written program or one lacking accuracy limits; intervals with no rationale; calibrations performed but not documented; out-of-tolerance results without remedial action or product-impact evaluation; and instruments used past their due dates.
The pattern to notice: FDA doesn’t just want calibration done — it wants a written program with limits and a documented response when those limits are exceeded. Certificates with as-found/as-left data, uncertainty, and NIST traceability are what make “remedial action” assessable. That’s the format every American Gage certificate follows, under A2LA ISO/IEC 17025:2017 accreditation (certificate 4296.01).
Typical GMP calibration workload
In pharma and biotech facilities, the instruments under Part 211 programs usually include:
- Balances and scales (with weight sets on their own cycle)
- Pipettes and liquid handling (ISO 8655 methods)
- Temperature devices — chambers, freezers, incubators, dataloggers, probes
- Pressure gauges and transmitters on process and utilities
- pH, conductivity, and analytical bench instruments
- Timers, tachometers, and packaging-line devices
Common questions
Does 21 CFR Part 211 specify calibration intervals?
No — it requires “suitable intervals” under a written program you define and justify. Manufacturer guidance, usage, and as-found history are the accepted bases; the interval rationale should be documented.
What must a Part 211 calibration record show?
Enough to demonstrate the written program was followed: the instrument, standards used and traceability, results against your accuracy limits (as-found/as-left), who performed it and when — and remedial action records when limits were exceeded.
Can we use an outside calibration lab under FDA GMPs?
Yes — outside labs are standard practice. You remain responsible for supplier qualification, which is why an accredited lab’s A2LA scope, certificate format, and quality documentation matter to your vendor file.